| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,548 | 16,035 | 20,092 | 23,875 | | Cost of Revenue | 12,699 | 11,764 | 14,831 | 16,921 | | | Gross Profit | 4,849 | 4,271 | 5,261 | 6,954 | | | Operating Expenses | | Research Development | 578 | 404 | 332 | 426 | | Selling General and Administrative | 4,350 | 3,953 | 3,913 | 5,477 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 358 | 374 | 373 | 373 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (437) | (460) | 644 | 677 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (541) | (125) | (923) | (138) | | Earnings Before Interest And Taxes | (978) | (584) | (280) | 539 | | Interest Expense |
-
|
-
|
-
| 582 | | Income Before Tax | (978) | (584) | (280) | (43) | | Income Tax Expense | 254 | 272 | 196 | 640 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,232) | (857) | (476) | (874) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,232) | (857) | (476) | (874) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,232) | ($857) | ($476) | ($874) |
|
0.31% Nasdaq 
0.05%
Income Statement
